Products Affected - Description

• • Atropine Sulfate injection, Hikma, 0.4 mg/mL, 20 mL multiple dose vial, 10 count, NDC 00641-6251-10
  • Atropine Sulfate injection, Pfizer, 0.1 mg/mL, 10 mL Ansyr syringe, 10 count, NDC 00409-1630-10
  • Atropine Sulfate injection, Pfizer, 0.1 mg/mL, 10 mL 21 gauge LifeShield syringe, 10 count, NDC 00409-4911-34
  • Atropine Sulfate injection, Pfizer, 0.1 mg/mL, 5 mL LifeShield syringe, 10 count, NDC 00409-4910-34

Reason for the Shortage

• • American Regent has atropine injection available.
  • Amphastar has atropine injection available.
  • Fresenius Kabi has atropine injection available.
  • Hikma did not provide a reason for the shortage.
  • Medefil has atropine injection available.
  • Pfizer has atropine injection on shortage due to manufacturing delays.

Available Products

• • Atropine Sulfate injection, American Regent, 0.4 mg/mL, 1 mL single dose vial, 25 count, NDC 00517-1004-25
  • Atropine Sulfate injection, American Regent, 1 mg/mL, 1 mL single dose vial, 25 count, NDC 00517-1001-25
  • Atropine Sulfate injection, Amphastar, 0.1 mg/mL, 10 mL Luer-Jet syringe, 10 count, NDC 76329-3339-01
  • Atropine Sulfate injection, Fresenius Kabi, 0.4 mg/mL, 20 mL multiple dose vial, 10 count, NDC 63323-0580-20
  • Atropine Sulfate injection, Medefil, Inc., 0.1 mg/mL, 10 mL syringe, 10 count, NDC 64253-0400-30
  • Atropine Sulfate injection, Pfizer, 0.05 mg/mL, 5 mL Ansyr syringe, 10 count, NDC 00409-9630-05

• • Hikma has atropine 0.4 mg/mL 20 mL vials on back order and the company estimates a release date of late-April to early-May 2024.
  • Pfizer has atropine 0.1 mg/mL 10 mL Ansyr syringes and 0.1 mg/mL 10 mL LifeShield syringes on back order and the company estimates a release date of May 2024 for the 0.1 mg/mL Ansyr syringes and June 2024 for the 0.1 mg/mL 10 mL LifeShield syringes. The 0.1 mg/mL 5 mL LifeShield syringes are available for emergency use via direct orders only.